Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
3 Results for "
CDK9-IN-6
" in MedChemExpress (MCE) Product Catalog:
Products (3)
3 Results for "CDK9-IN-6" in MCE Product Catalog:
Cat. No.: HY-149963
CAS No.: 2935587-91-8
PROTAC CDK9 degrader-6 is a PROTAC targeting to CDK9 sepcifically. PROTAC CDK9 degrader-6 mediates CDK9 degradation via the proteasome. PROTAC CDK9 degrader-6 degrades CDK9 with DC50s of 0.10 μM and 0.14 μM for the CDK942 and CDK955 isoforms, respectively .
Cat. No.: HY-184978
CAS No.: 2305936-79-0
Research Areas:
Thalidomide-NH-CO-NH-C10-COOH is a conjugate of an E3 ligase ligand and a linker, which can be used for the synthesis of PROTACs, such as PROTAC CDK9 degrader-6 (HY-149963) .
Cat. No.: HY-184694
Research Areas:
CDK9 ligand 6 is a PROTAC target protein ligand targeting CDK9, which can be used in research related to PROTAC synthesis, such as serving as the target protein ligand for PROTAC CDK9 degrader-13 (HY-184693) .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
